NLS PHARMACEUTICS LTD (NLSP)
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
